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Dihydrosqualene derivativesAbstract The total extract of Albizia lebbeck flowers was examined in vivo for its possible hepato-
protective activity in comparison with the standard drug silymarin at two doses. The higher dose
expressed promising activity especially in reducing the levels of AST, ALT and bilirubin. Fraction-
ation via liquid–liquid partition and reexamination of the fractions revealed that the n-butanol frac-
tion was the best in improving liver biochemical parameters followed by the n-hexane fraction.
However, serum lipid parameters were best improved with CHCl3 fraction. The promising biological
activity results initiated an intensive chromatographic purification of A. lebbeck flowers fractions.
Two compounds were identified from natural source for the first time, the acyclic farnesyl sesquiter-
pene glycoside1-O-[6-O-a-L-arabinopyranosyl-b-D-glucopyranoside]-(2E,6E-)-farnesol (6) and the
squalene derivative 2,3-dihydroxy-2,3-dihydrosqualene (9), in addition to eight compounds reported
here for the first time from the genus Albizia; two benzyl glycosides, benzyl 1-O-b-D-glucopyranoside
(1) and benzyl 6-O-a-L-arabinopyranosyl b-D-glucopyranoside (2); three acyclic monoterpene glyco-
sides, linalyl b-D-glucopyranoside (3) and linalyl 6-O-a-L-arabinopyranosyl-b-D-glucopyranoside (4);
(2E)-3,7-dimethylocta-2,6-dienoate-6-O-a-L arabinopyranosyl-b-D-glucopyranoside (5), two oligo-
glycosides, n-hexyl-a-L arabinopyranosyl-(1? 6)-b-D-glucopyranoside (creoside) (7) and n-octyl
a-L-arabinopyranosyl-(1? 6)-b-D-glucopyranoside (rhodiooctanoside) (8); and ethyl fructofura-
noside (10). The structures of the isolated compounds were elucidated based on extensive1, Saudi
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Pharmaceutical Journal (2016), http://dx.doiexamination of their spectroscopic 1D and 2D-NMR, MS, UV, and IR data. It is worth mentioning
that, some of the isolated linalol glycoside derivatives were reported as aroma precursors.
 2016 The Authors. Production and Hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The genus Albizia (Fabaceae), embraces around 150 species,
mostly trees and shrubs native to warm areas of Asia and
Africa (Migahed, 1996). It is widely cultivated in tropical
and subtropical regions as an ornamental plant. A perusal of
the literature revealed that plants belonging to genus Albizia
have great medicinal values. A. anthelmintica A. Brogne is used
for the treatment of malaria and febrile convulsions (Carpani
et al., 1989; Johns et al., 1994), while the leaves, boiled with
water, are given by traditional healers in Dar es Salaam, Tan-
zania, for the treatment of epilepsy (Moshi et al., 2005). On the
other hand, the bark of Albizia odoratissima is used to treat
cough, bronchitis, rheumatism and diabetes (Kumar et al.,
2011). Seeds of Albizia amara are used in the treatment of piles,
diarrhea and gonorrhea (Gundamaraju et al., 2014).
Since the fifties of the last century, genus Albizia has been a
rich source of several classes of bioactive secondary metabolites
including saponins, tannins, alkaloids, flavonoids and phenolic
glycosides (El-Mousallamy, 1998; Kang et al., 2007; Sanjay,
2003; Varshney and Farooq, 1952). Recently, an antitumor
triterpene saponin julibroside J28, isolated from the stem bark
of Albizia julibrissin has displayed significant, in vitro, antitu-
mor activity against PC-3M-1E8, Bel-7402 and HeLa cancer
cell lines at 10 lM assayed by SRB method (Liang et al., 2005).
Albizia lebbeck L. is one of the most common species of
Albizia worldwide, known by various names such as Indian
siris, flea tree, frywood, koko and Laback in Arabic. The tree
was imported to Saudi Arabia from India, years ago, as an
ornamental tree, well adapted to the hot environmental condi-
tions of Najd state in the central region of Saudi Arabia
(El Gamal et al., 2015).
It is usually flowering, between April and September, with
cream-colored fragrant hermaphroditic flowers (Migahed,
1996). The plant is well-known, in traditional folk medicine,
for the treatment of various ailments in several areas around
the world. In Ayurveda, all parts of the tree including roots,
leaves, bark and flowers are used to cure asthma and other
inflammatory conditions such as, arthritis and burns
(Ayurvedic Pharmacopoeia of India, 2001). In traditional Chi-
nese medicine the flowers are commonly used to treat anxiety,
depression and insomnia (Kang et al., 2007). The decoction of
the flower in a dose of 50 mg/kg induces muscle relaxation and
can protect the guinea pig against histamine-induced bron-
chospasm (Tripathi and Das, 1977).
In our previous research on A. lebbeck, we found that dif-
ferent fractions from the flowers of A. lebbeck possessed anti-
pyretic, analgesic, estrogenic and anti-inflammatory activities
(Farag et al., 2013). Our earlier phytochemical study of the
alcoholic extract of the flowers led to the isolation of taraxerol
triterpenes, ceramide derivatives and two flavonoids, in addi-
tion to a novel b-lactam derivative, albactam, which was also
evaluated for platelet anti-agreggatory effect (El Gamal
et al., 2015).ni, S.M. et al., New acyclic secondary m
.org/10.1016/j.jsps.2016.05.006In view of the versatile biological activities of this plant and
as a part of our continuing interest in identifying biologically
active drug leads from natural sources, we conducted this
research with the aim of discovering new compounds with hep-
atoprotective potential.2. Materials and methods
2.1. General experimental procedures
1H and 13C NMR spectra were recorded at NMR Unit at the
College of Pharmacy, Sattam Bin Abdulaziz University on a
UltraShield Plus 500 MHz (Bruker) spectrometer operating
at 500 MHz for proton and 125 MHz for carbon, respectively.
The chemical shift values are reported in d (ppm) relative to
the internal standard TMS or residual solvent peak, and the
coupling constants (J) are reported in Hertz (Hz). 2D-NMR
experiments (COSY, HSQC, HMBC and NOESY) were
obtained using standard Bruker program. Jeol JMS-700 High
Resolution Mass Spectrophotometer was used for accu-
rate mass determination. Electron Impact mode with ioniza-
tion energy of 70 eV was accustomed. Direct probe,
temperature ramp setting was used with initial temperature
50 C; increasing 32 C per minute and final temperature
350 C set up, and resolution was adjusted to 10k. Thin layer
chromatography (TLC) was performed on pre-coated silica
gel F254 plates (E. Merck, Darmstadt, Germany); detection
was done at 254 nm and by spraying with p-anisaldehyde/
H2SO4 reagent followed by heating at 110 C for 1–2 min.
Centrifugal preparative thin layer chromatography (CPTLC)
was performed on chromatotron (Harrison Research, Palo
Alto, California, CA, USA). Plates coated with 2 mm of silica
gel 60, 0.04–0.06 mm were used. All solvents used were of ana-
lytical grade. Silymarin was purchased from Sigma Aldrich
(St. Louis, USA).
2.2. Plant materials
The flowers of A. lebbeck Linn. were collected in April, 2011,
from Riyadh, kingdom of Saudi Arabia. The plant was identi-
fied by Dr. Mohammed Yusuf, taxonomist of the Medicinal,
Aromatic and Poisonous Plants Research Center (MAPPRC),
College of Pharmacy, King Saud University, Riyadh, Saudi
Arabia. A voucher specimen (# 16182) has been deposited at
the Pharmacognosy Department, College of Pharmacy, King
Saud University, Riyadh, Saudi Arabia.
2.3. Extraction, fractionation and isolation
The air-dried powdered flowers of A. lebbeck (1 kg) were
extracted with 80% ethanol (3  4 L) at room temperature.
The pooled extracts were concentrated under reduced pressure
using rotatory evaporator to get a dark brownish residueetabolites from the biologically active fraction of Albizia lebbeck flowers. Saudi
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(400 mL) and filtered to remove the precipitated insoluble part.
The dried methanol-soluble fraction (55 g) was dissolved in
40% ethanol and successively partitioned with n-hexane
(300 mL  4), chloroform (300 mL  4), ethyl acetate
(300 mL  4) and n-butanol (300 mL  4) to provide the cor-
responding fractions. The n-hexane fraction (12 g) was sub-
jected to column chromatography on pre-packed silica gel
column (35 mm i.d.  350 mm) using n-hexane–ethyl acetate
gradient; collected fractions were examined with TLC and sim-
ilar fractions were pooled together. The fraction eluted with
n-hexane/EtOAc (20/80) was further purified by subjecting to
RP-18 column (120 g  60 cm  3 cm) using MeOH/CH3CN,
10/90 to give an almost pure compound which was further
purified on the chromatotron using solvent system 1% ace-
tone–CHCl3 to give compound 9 (25 mg).
The chloroform fraction (13 g) was applied on a silica gel
column using CHCl3/MeOH gradient and collected fractions
were grouped to obtain four main subfractions: A (3.7 g), B
(3.4 g), C (2.6 g) and D (3.3 g). Fraction A was rechro-
matographed on a RP-18 column (MeOH–H2O, gradient) to
yield compound 10 (15 mg). Fraction B was subjected to
purification by chromatotron (8% MeOH/CHCl3), followed
by RP-18 column chromatography (MeOH–H2O, 65:35) to
yield compound 4 (23 mg). Fraction C was purified on a RP-
18 column (MeOH–H2O, 65:35) to give compound 5 (8 mg),
while compound 6 (19 mg) was obtained by RP-18 column
(10% MeOH/H2O) of fraction D.
The n-butanol fraction (10 g) was chromatographed on
Diaion HP-20 column, using MeOH/H2O gradient to afford
two main subfractions (i and ii). Sub fraction i, eluted with
40%MeOH/H2O was further subjected to column chromatog-
raphy (CHCl3/MeOH, gradient) to afford compounds 1–3
(using 9–15%MeOH/CHCl3 as eluents respectively). Sub frac-
tion ii, eluted with 60% MeOH/H2O was further subjected to
RP-18 column chromatography (100 g  50 cm  3 cm,
MeOH/H2O gradient) to afford compounds 7 and 8 (eluted
with 50% and 65% MeOH/H2O respectively).
2.4. Animals
Wistar male albino rats weighing 150–200 g, almost the same
age (8–10 weeks), obtained from the Experimental Animal
Care Center, College of Pharmacy, King Saud University,
Riyadh, were used. The animals were kept under constant
temperature (22 ± 2 C), humidity (55%) and light/dark con-
ditions (12/12 h). They had ad libitum access to a dry commer-
cial diet and free access to drinking water (Abdel-Kader et al.,
2010). The procedures and experiments used in this research
were approved by the Ethics Committee of the College of
Pharmacy, King Saud University.
2.5. Hepatoprotective activity
The male albino rats were randomly assigned into four groups
(5 animals each). Group IV was divided into eight sub groups
of five animals each. Group I received only normal saline and
served as control. Groups I–IV received single dose of CCl4
(1.25 mL/kg body weight). Group II received CCl4 treatment
only. Group III administered silymarin at a dose of 10 mg/
kg p.o. The sub groups of were treated with 200, 400 mg/kgPlease cite this article in press as: Al-Massarani, S.M. et al., New acyclic secondary m
Pharmaceutical Journal (2016), http://dx.doi.org/10.1016/j.jsps.2016.05.006of the total extract, 50 and 100 mg/kg of the different fractions.
Treatment started 6 days prior to CCl4 and continued till day
seven. After 24 h, following CCl4 administration in day 7, the
animals were sacrificed using ether anesthesia. Blood samples
were collected by heart puncture and the serum was separated
to evaluate the biochemical parameters (Abdel-kader and
Alqasoumi, 2008).
2.6. Determination of AST, ALT, GGT, ALP, bilirubin,
cholesterol, triglycerides, HDL, LDL and VLDL levels
Five biochemical parameters, aspartate aminotransferase
(AST), alanine aminotransferase (ALT), gamma glutamyl-
transpeptidase (GGT), alkaline phosphatase (ALP) and total
bilirubin were estimated, as reflection of liver function, by
reported method (Edwards and Bouchier, 1991). The enzyme
activities were measured using diagnostic strips (Reflotron,
ROCHE) and were read on a ReflotronPlus instrument
(ROCHE). TG (Foster and Dunn, 1973), TC (Zlatkis et al.,
1953), HDL-C (Burstein et al., 1970), LDL-C and VLDL
(Friedwald et al., 1972) were assessed using Roche Diagnostics
Kits.
2.7. Determination of non-protein sulfhydryl groups (NP-SH),
malonaldehyde (MDA) and total protein (TP)
The livers were separately cooled in a beaker immersed in an
ice bath. The tissues were homogenized in 0.02 M ethylenedi-
aminetetraacetic acid (EDTA) in a Potter-Elvehjem type C
homogenizer.
Homogenate equivalent of 100 mg tissues was used for the
measurements. Non-protein sulfhydryl groups (NP-SH) and
MDA were quantified spectrophotometrically as previously
described (Sedlak and Lindsay, 1968).
Total protein was determined according to the method of
Lowry et al. (1951) Homogenates were treated with 0.7 mL
of Lowry’s solution, mixed and incubated for 20 min in dark
at room temperature. Diluted Folin’s reagent (1 mL) was then
added and samples were incubated at room temperature in
dark for 30 min. The absorbance of the resulted solutions
was then measured at 750 nm (Lowry et al., 1951).
2.8. Statistical analyses
Results are expressed as Mean ± Standard Error (SE) of
mean. Statistical analysis was achieved, using a one-way anal-
ysis of variance (ANOVA). When, the F-value was found
statistically significant (p< 0.05), further comparisons among
groups were made using Dunnett’s multiple comparisons test.
All statistical analyses were performed using SPSS software
17.0 (Released Aug. 23, 2008), Chicago, USA.3. Results
Phytochemical study of A. lebbeck flowers resulted in the isola-
tion of ten compounds, benzyl 1-O-b-D-glucopyranoside (1),
benzyl 6-O-a-L-arabinopyranosyl b-D-glucopyranoside (2), lina-
lyl b-D-glucopyranoside (3), linalyl 6-O-a-L-arabinopyranosyl-
b-D-glucopyranoside (4), (2E)-3,7-dimethylocta-2,6-dienoate-
6-O-a-L arabinopyranosyl-b-D-glucopyranoside (5), 1-O-[6-O-etabolites from the biologically active fraction of Albizia lebbeck flowers. Saudi
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(6) n-hexyl-a-L arabinopyranosyl-(1? 6)-b-D-glucopyranoside
(creoside) (7), n-octyl a-L-arabinopyranosyl-(1? 6)-b-D-
glucopyranoside (Rhodiooctanoside) (8), 2,3-dihydroxy-2,3-di
hydrosqualene (9) and ethyl fructofuranoside (10). The struc-
tures of the compounds are presented in Fig. 1.
The total alcoholic extract, n-hexane, chloroform (CHCl3)
and n-butanol fractions were tested for hepatoprotective effect
against CCl4 induced toxicity. The results are shown in Tables
4 and 5.
3.1. The physical and spectral data of compounds 1–10
3.1.1. Benzyl 1-O-b-D-glucopyranoside (1)
C13H18O6; white solid;
1H NMR (500 MHz, MeOD): dH 7.43
(br d, H-2/6), 7.33 (br t H-3/5), 7.28 (m, H-4), 4.93 (d,
J= 11.9 Hz, H-7a), 4.70 (d, J= 11.9 Hz, H-7b), 4.34 (d,
J= 7.5 Hz, H-10), 3.20 (m, H-20), 3.35 (m, H-30), 3.36 (m, H-
40), 3.17 (m, H-50), 3.80 (dd, J= 11.8, 2.5 Hz, H-60-a), 3.65
(dd, J= 11.8, 5.6 Hz, H-60b); 13C NMR (125 MHz, MeOD):
dC 139.1 (C-1), 129.4 (C-2/6), 129.4 (C-3/5), 128.8 (C-4), 71.8
(C-7), 103.3 (C-10), 75.1 (C-20), 78.0 (C-30), 71.8 (C-40), 78.1
(C-50), 62.8 (C-60); HREIMS m/z 270.2780 [M+].
3.1.2. Benzyl-6-O-a-L-arabinopyranosyl b-D-glucopyranoside
(2)
C18H26O10; white solid; 1H NMR (500 MHz, MeOD): dH 7.43
(br d, H-2/6), 7.33 (br t H-3/5), 7.28 (m, H-4), 4.93
(d, J= 11.9 Hz, H-7a), 4.70 (d, J= 11.9 Hz, H-7b), 4.35 (d,
J= 8.0 Hz, H-10), 3.22 (t, J= 8.1 Hz, H-20), 3.42 (d,
J= 2.3 Hz, H-30), 3.43 (m, H-40), 3.44 (m, H-50), 4.33
(dd, J= 11.0, 5.7 Hz, H-60a), 3.75 (dd, J= 11.0, 5.6 Hz,
H-60b), 4.34 (d, J= 7.0 Hz, H-10 0), 3.59 (dd, J= 9.0, 7.1 Hz,
H-200), 3.64 (dd, J= 9.1, 3.0 Hz, H-30 0), 3.95 (m, H-40 0), 3.89
(dd, J= 13.0, 2.2 Hz, H-500a), 3.65 (br d, J= 12.4 Hz,R1O
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Figure 1 Chemical structures of the isolat
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(C-2/6), 129.3 (C-3/5), 128.9 (C-4), 72.0 (C-7), 103.4 (C-10),
75.1 (C-20), 77.9 (C-30), 71.6 (C-40), 76.9 (C-50), 69.6 (C-60),
105.3 (C-100), 72.4 (C-20 0), 74.2 (C-300), 69.6 (C-40 0), 66.9
(C-500); HREIMS m/z 402.1526 [M+].
3.1.3. Linalyl-b-D-glucopyranoside (3)
C16H28O6; white viscous liquid;
1H NMR (500 MHz, MeOD):
dH 5.17 (d, J= 11.3 Hz, H-1-a), 5.22 (d, J= 18.0 Hz, H-1-b),
6.07 (dd, J= 17.7, 11.0 Hz, H-2), 1.64 (m, H-4), 2.04 (m, H-5),
5.11 (br t, J= 7.0 Hz, H-6), 1.68 (s, H-8), 1.61 (s, H-9), 1.35 (s,
H-10), 4.33 (d, J= 7.4 Hz, H-10), 3.18 (m, H-20), 3.34 (m, H-
30), 3.36 (m, H-40), 3.16 (m, H-50), 3.80 (dd, J= 11.9, 2.3 Hz,
H-60-a), 3.65 (dd, J= 11.9, 5.5 Hz, H-60-b), 13C NMR
(125 MHz, MeOD): dC 115.1 (C-1), 144.5 (C-2), 81.5 (C-3),
41.6 (C-4), 23.5 (C-5), 125.8 (C-6), 32.2 (C-7), 23.7 (C-8),
26.0 (C-9), 17.9 (C-10), 99.2 (C-10), 75. 1 (C-20), 78.2 (C-30),
71.7 (C-40), 77.6 (C-50), 62. 9 (C-60); HREIMS m/z
316.1886 M+].
3.1.4. Linalyl-6-O-a-L-arabinopyranosyl-b-D-glucopyranoside
(4)
C21H36O10; viscous liquid;
1H NMR (500 MHz, MeOD): dH
5.22 (d, J= 11.3 Hz, H-1a,), 5.17 (d, J= 11.3 Hz, H-1b),
6.09 (dd, J= 17.7, 11.0 Hz, H-2), 1.56 (m, H-4a), 1.62 (m,
H-4b,), 2.07 (m, H-5a), 2.04 (m, H-5b), 5.11 (br t,
J= 7.0 Hz, H-6), 1.68 (s, H-8), 1.61 (s, H-9), 1.35 (s, H-10)
4.35 (d, J= 7.9 Hz, H-10), 3.20 (t, J= 8.0, H-20), 3.40 (m,
H-30), 3.43 (m, H-40), 3.43 (m, H-50), 4.33 (dd, J= 11.0,
5.7 Hz, H-60a), 3.75 (dd, J= 11.0, 5.5 Hz, H-60b), 4.33 (d,
J= 7.0 Hz, H-10 0), 3.60 (dd, J= 9.0, 7.0 Hz, H-20 0), 3.63
(dd, J= 9.1, 3.0 Hz, H-300), 3.93 (m, H-40 0), 3.88 (dd,
J= 13.0, 2.2 Hz, H-500a), 3.66 (br d, J= 12.4 Hz, H-50 0b);
13C NMR (125 MHz, MeOD): dC Table 2; HREIMS m/z
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Table 2 13C NMR data of compounds 1–8 (125 MHz,
MeOD).
1 2 3 4 5 6 7 8
1 139.1 139.1 115.1 115.1 166.5 66.7 71.1 71.1
2 129.4 129.4 144.5 144.3 115.9 121.6 30.8 30.8
3 129.3 129.3 81.5 81.5 164.5 142.4 26.8 27.1
4 128.8 128.9 41.6 41.7 42.0 40.8 32.9 30.6
5 129.3 129.3 23.5 23.8 27.1 27.5 23.7 30.4
6 129.4 129.4 125.8 125.8 124.1 125.2 14.4 33.0
7 71.8 72.0 132.2 132.2 133.6 136.3 – 23.7
8 – – 23.7 26.0 25.9 40.9 – 14.5
9 – – 26.0 23.7 17.8 27.9 – –
10 – – 17.9 17.9 19.3 125.5 – –
11 – – – – – 132.1 – –
12 – – – – – 26.1 – –
13 – – – – – 17.9 – –
14 – – – – – 16.3 – –
15 – – – – – 16.8 – –
10 103.3 103.4 99.2 99.3 95.2 103.0 104.4 104.4
20 75.1 75.1 75.1 75.1 77.9 75.0 75.2 75.2
30 78.0 77.9 78.2 78.2 77.6 77.9 78.1 78.1
40 71.8 71.6 71.7 71.7 73.9 71.5 71.7 71.7
50 78.1 76.9 77.6 76.4 71.2 76.8 76.9 76.8
60 62.8 69.6 62.9 69.4 69.2 69.5 69.6 69.5
10 0 – 105.3 – 104.9 104.8 105.1 105.2 105.2
20 0 – 72.4 – 72.5 72.4 72.4 72.5 72.5
30 0 – 74.2 – 74.2 74.2 74.2 74.4 74.4
40 0 – 69.6 – 69.4 69.6 69.4 69.5 69.6
50 0 – 66.9 – 66.4 66.8 66.8 66.8 66.8
Secondary metabolites from fraction of Albizia lebbeck flowers 53.1.5. (2E)-3,7-dimethylocta-2,6-dienoate-6-O-a-L-
arabinopyranosyl-b-D glucopyranoside (5)
C21H34O11; colorless amorphous powder;
1H NMR Table 1;
13C NMR Table 2; HREIMS m/z 462.2101 [M+].
3.1.6. 1-O-[6-O-a-L-arabinopyranosyl b-D-glucopyranoside] –
(2E,6E-)-farnesol (6)
C26H44O10; viscous liquid;
1H NMR Table 1; 13C NMR
Table 2; HREIMS m/z 516.2934 [M+].
3.1.7. Hexyl-a-L arabinopyranosyl-(1? 6)-b-D-
glucopyranoside (Creoside IV) (7)
C17H32O10; colorless amorphous powder;
1H NMR Table 1;
13C NMR Table 2; HREIMS m/z 396.1995 [M+].
3.1.8. Octyl-a-L arabinopyranosyl-(1? 6)-b-D-glucopyranoside
(rhodiooctanoside) (8)
C19H36O10; white amorphous powder;
1H NMR Table 1; 13C
NMR Table 2; HREIMS m/z 424.2308 [M+].
3.1.9. 2,3-Dihydroxy-2,3-dihydrosqualene (9)
C30H52O2; oily;
1H NMR (500 MHz, MeOD): dH 1.16 (s, H-1),
1.22 (s, H-25), 1.60–1.70 (18 H, s, CH3-24,26–30), 1.98–2.22
(m, CH2-4,5,8,9,12,13,16,17,20,21), 5.22 (H-7), 3.37 (d,
J= 7.5 Hz, H-3), 5.12–5.22 (5H, t, J= 6.1 Hz, C-H-
7,11,14,18,22); 13C NMR (125 MHz, MeOD): dC 23.2 (C-1),
73.1 (C-2), 78.3 (C-3), 29.7 (C-4), 36.8 (C-5), 135.2 (C-6),
124.3 (C-7), 26.8 (C-8), 39.8 (C-9), 134.9 (C-10), 124.4 (C-Table 1 1H NMR data of compounds 5–8 (500 MHz, MeOD).
5 6 7 8
1 – 4.21 (dd, J= 11.8, 7.5 Hz);
4.36 (dd, J= 9.3, 6.5 Ha)
4.20 (dd, J= 12.4, 7.6 Hz) 3.83 (m)
4.35 (dd, J= 12.4, 6.9 Hz)
2 5.76 (s) 5.41 (t, J= 6.5 Hz) 1.61 (m) 1.61 (m)
3 – – 1.37 (m) 1.22–1.47 (m)
4 2.23 (m) 2.08 (m) 1.34 (m)
5 2.23 (m) 2.16 (m) 1.34 (m)
6 5.20 (dd, J= 6.6, 6.9 Hz) 5.14 (m) 0.91 (t, J= 6.8 Hz)
7 – – –
8 1.70 (s) 1.99 (m) – 0.90 (t, J= 6.9 Hz)
9 1.64 2.10 (m) – –
10 2.20 (s) 5.11 (m) – –
11 – – – –
12 – 1.69 (s) – –
13 – 1.62 (s) – –
14 – 1.63 (s) – –
15 – 1.72 (s) – –
10 5.49 (d, J= 8.2 Hz) 4.32 (d, J= 7.9 Hz) 4.26 (d, J= 8.0 Hz) 4.22 (d, J= 8.0 Hz)
20 3.55 (m) 3.23 (t, J= 8.2 Hz) 3.18 (dd, J= 8.2, 8.9 Hz), 3.19 (m)
30 3.46 (dd, J= 8.9, 8.9 Hz) 3.40 (d, J= 2.3 Hz) 3.34 (m) 3.32 (m)
40 3.53 (m) 3.42 (m) 3.34 (m) 3.32 (m)
50 3.39 (m) 3.43 (m) 3.42 (m) 3.40 (m)
60 4.12 (dd, J= 11.2, 2.1 Hz) 4.11 (dd, J= 11.5, 1.9 Hz) 4.09 (brd, J= 10.0 Hz) 4.09 (brd, J= 11.4 Hz)
3.75 (dd, J= 11.2, 5.3 Hz) 3.76 (dd, J= 11.1, 5.8 Hz) 3.73 (m) 3.77 (d, J= 6.6 Hz)
10 0 4.30 (d, J= 6.8 Hz) 4.33 (d, J= 6.8 Hz) 4.32 (d, J= 6.5 Hz) 4.31 (d, J= 6.7 Hz)
20 0 3.57 (dd, J= 6.4, 8.5 Hz) 3.60 (dd, J= 9.3, 7.0 Hz) 3.59 (m) 3.62 (m)
30 0 3.37 (dd, J= 8.2, 8.7 Hz) 3.65 (dd, J= 9.3, 3.1) 3.53 (m) 3.53 (m)
40 0 3.81 (m) 3.97 (m) 3.80 (m) 3.82 (m)
50 0 3.87 (dd, J= 3.2, 12.5 Hz) 3.90 (dd, J= 12.6, 2.1 Hz) 3.85 (m) 3.83 (m)
3.53 (dd, J= 5.3, 11.2 Hz) 3.66 (brd, J= 12.4 Hz) 3.52 (m)
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6 S.M. Al-Massarani et al.11), 28.3 (C-12), 26.4 (C-13), 124.4 (C-14), 135.0 (C-15), 39.8
(C-16), 26.7 (C-17), 125.1 (C-18), 134.9 (C-19), 39.8 (C-20),
26.7 (C-21), 124.2 (C-22), 131.3 (C-23), 23.3 (C-24), 25.7
(C-25), 15.9 (C-26), 16.0 (C-27), 16.0 (C-28), 16.1 (C-29),
17.7 (C-30); HREIMS m/z 444.3967 [M+].
3.1.10. 4-Ethyl fructofuranoside (10)
C8H16O6; viscous liquid;
1H NMR (500 MHz, MeOD): dH
3.90 (m, H-1), 3.70 (dd, J= 2.8, 3.0 Hz, H-2), 4.04 (d,
J= 2.8 Hz, H-3), 3.66, 3.90 (dd 2.5, 12.00 CH2-5), 3.56, 3.77
(m, CH2-6), 3.57 (m, J= 7.4 Hz CH2-1
0), 1.20 (t, J= 7.5 Hz
CH3-2
0), 5.15 13C NMR (125 MHz, MeOD): dC 84.1 (C-1),
78.6 (C-2), 83.0 (C-3), 109.0 (C-4), 61.5 (C-5), 62.7 (C-6),
57.8 (C-10), 16.1 (C-20); HREIMS m/z 208.0947 [M+].
4. Discussion
The administration of CCl4 causes damage of the hepatocytes
which is reflected by increase in the biochemical parameter
levels such as aspartate aminotransferase (AST), alanine
aminotransferase (ALT), gamma glutamyl transpeptidase
(GGT), alkaline phosphatase (ALP), and total bilirubin
(Table 3). Investigation of the curative potentials of the total
alcoholic extract at two doses revealed that pretreatment of
rats with 400 mg/kg provided protection comparable to that
of silymarin. The levels of AST, ALT, GGT and bilirubin were
reduced by 52.01%, 33.67%, 29.67% and 48.05% respectively.
The least improvement was observed in the level of ALP
(18.89%). All results were highly significant (p< 0.001)
(Table 3). Liquid–Liquid fractionation of the total extracts
with n-hexane, CHCl3 and n-butanol and evaluation of the
hepatoprotective potential of the fractions at 50 and 100 mg/
kg revealed that the n-butanol fraction is the most active in
reduction of the levels of AST (36.54%), ALT (48.56%),
MDA (1.82 ± 0.20) and restoring the levels of NP-SH (4.50
± 0.30) and total protein (82.19 ± 0.19) (p< 0.001 and
p< 0.01) (Tables 3 and 5). In the second place in improving
these parameters comes the n-hexane fraction (Tables 3 and
5). However, the CHCl3 fraction was superior in the improve-
ment of blood lipid picture (Table 4). Cholesterol, triglyc-
erides, HDL, LDL and VLDL were improved significantly
(p< 0.001) following the treatment of the rats with 100 mg/
kg.
Phytochemical analysis of the n-hexane, chloroform and n-
butanol fractions obtained from the flowers of A. lebbeck led
to the isolation of two benzyl glycosides, benzyl 1-O-b-D-
glucopyranoside (1) (De Rosa et al., 1996; Wen et al., 2012)
and benzyl 6-O-b-L-arabinopyranosyl b-D-glucopyranoside
(2) (Chassagne et al., 1996); three acyclic monoterpene glyco-
sides, linalyl b-D-glucopyranoside (3) (Moon et al., 1994), lina-
lyl 6-O-a-L-arabinopyranosyl-b-D-glucopyranoside (4)
(Chassagne et al., 1996; Pabst et al., 1991) and (2E)-3,7-
dimethylocta-2,6-dienoate-6-O-a-L-arabinopyranosyl-b-D-
glucopyranoside (5) (Yang et al., 2013), an acyclic sesquiter-
pene glycoside 1-O-[6-O-a-L-arabinopyranosyl-b-D-
glucopyranoside]-(2E,6E-)-farnesol (6) (Magid et al., 2005,
2008) in addition to creoside IV (7) (Nakamura et al., 2008),
octyl a-L arabinopyranosyl-(1? 6)-b-D-glucopyranoside (rho-
diooctanoside) (8) (Yoshikawa et al., 1996), the squalene
derivative, 2,3-dihydroxy-2,3-dihydrosqualene (9) (Brown
and Martens, 1977) and ethyl fructofuranoside (10) (LiuPlease cite this article in press as: Al-Massarani, S.M. et al., New acyclic secondary m
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and 2D-NMR and HREIMS and in correlation with known
compounds. The compounds 6 and 9 are reported here for
the first time from natural sources. On the other hand and
from the chemotaxonomic point of view, the sugar part of
the isolated bioside glycosides consists of a-L arabinopyra-
nosyl-(1? 6)-b-D-glucopyranoside which might be considered
as chemotaxonomic marker for A. lebbeck.
It is noteworthy that linalyl b-D-glucopyranoside (3) and
linalyl 6-O-a-L-arabinopyranosyl-b-D-glucopyranoside (4)
were reported as aroma precursors from Jasminum sambac
and passion fruit (Passiflora edulis), respectively (Chassagne
et al., 1996; Moon et al., 1994). On the other hand, ethyl
fructofuranoside (10) is formed as a by-product by the Wick-
erhamomyces anomala, a yeast strain capable of selective
utilization of fructooligosaccharides (FOSs) syrup (Lu et al.,
2013).
Compound 6 was obtained as a viscous liquid. HREIMS of
compound 6 showed a molecular ion peak at m/z 516.2934
[M+] suggesting the molecular formula C26H44O10 and 5
degrees of unsaturation. Careful examination of NMR spectra
for compound 6 revealed the presence of a farnesyl type
sesquiterpene glycoside. Its 13C NMR and DEPT spectrum
(Table 1) exhibited 26 carbons including four olefinic methyls,
seven methylenes, twelve methines nine of which are oxy-
genated and three quaternary carbons. The aglycone part
was proved to be a farnesyl type sesquiterpene by four olefinic
methyls observed in the NMR spectra, at dH 1.62, 1.63, 1.69
and 1.72, connected, in the HSQC, to carbons at dC 17.9,
16.3, 26.1 and 16.8 ppm; assigned for Me-13, Me-14, Me-12
and Me-15 respectively. Long range coupling was observed
between the olefinic protons at dH 5.11 ppm (H-10, m) and
Me-12 and Me-13; and 5.14 (H-6, m) and Me 14; and 5.41
(H-2, t) with Me-15. The presence of oxymethylene at C-1
was clarified by one pair of two coupled oxygenated protons
at dH 4.21 ppm (H-1a, dd, J= 11.8, 7.6 Hz), 4.36 ppm
(H-1b, dd, J= 9.3, 6.5 Hz), both showing cross peak correla-
tions with the olefinic proton at dH 5.41 (H-2, t, J= 6.45 Hz).
Moreover, NMR showed the presence of four upfield
methylene protons at dH 2.08 (H2-4, m), 2.16 (H2-5, m), 1.99
(H2-8, m) and 2.10 ppm (H2-9, m). The above mentioned spec-
tral data together with 15 carbon atoms ascribed by 13C NMR
and DEPT experiments as 4 methyls, 5 methylenes, three ole-
finic methines at dC 121.6, 125.2 and 125.5 ppm assigned for C-
2, C-6 and C-10 respectively and three quaternary carbons at
dC 132.2, 136.3 and 142.5 assigned for carbons 11, 7 and 3
respectively confirmed the presence of acyclic farnesyl type
sesquiterpene. The 13C NMR chemical shift values for the ole-
finic methyls, Me-14 and Me-15 observed at dC 16.3 and
16.8 ppm and those for the two methylene at C-4 and C-8
appeared at dC 40.8 and 40.9 ppm, respectively are closely sim-
ilar for those reported for (2E,6E)-farnesol (Kasai et al., 1986)
while the C-12 resonated at dC 20.1 ppm. The chemical struc-
ture of the sugar part of the molecule was confirmed to be a
bioside of b-D glucose and a-L-arabinose based on the data
obtained from 1D (1H, 13C, and DEPT) experiments and 2D
(COSY, HSQC and HMBC). The presence of two anomeric
protons at dH 4.32 and 4.33 ppm with large coupling constants
J= 7.9 and 6.8 correlates directly through one bond length in
HSQC to their carbons at dC 103.1 and 105.1 ppm indicating
the presence of b-D-glucose and a-L-arabinose respectively.
Additionally two oxymethylene protons appeared at dH 3.76etabolites from the biologically active fraction of Albizia lebbeck flowers. Saudi
Table 3 Effect of A. lebbeck total extract (Total) and fractions on serum marker enzymes of control and experimental rats.
Treatment (n= 5) Biochemical parameters
AST (units/l) %
Change
ALT (units/l) %
Change
GGT (units/l) %
Change
ALP (units/l) %
Change
Bilirubin (mg/dl) %
Change
Normal 106.01 ± 5.44 29.48 ± 1.50 3.55 ± 0.27 283.00 ± 14.36 0.53 ± 0.02
CCl4 297.66 ± 10.01
***,a 192.5 ± 5.70***,a 10.90 ± 0.41***,a 503.66 ± 14.84***,a 2.22 ± 0.16***,a
Silymarin 119.83 ± 5.68***,b 59.72 100.68 ± 4.27***,b 47.69 6.28 ± 0.29***,b 42.36 372.00 ± 13.03***,b 36.14 1.08 ± 0.04***,b 51.49
Total 200 mg 163.16 ± 5.05***,b 45.18 139.50 ± 3.76***,b 27.53 8.31 ± 0.30***,b 23.91 452.50 ± 5.97*,b 10.15 1.33 ± 0.04***,b 40.04
Total 400 mg 142.83 ± 4.72***,b 52.01 127.66 ± 3.48***,b 33.67 7.66 ± 0.22***,b 29.67 408.50 ± 7.57***,b 18.89 1.15 ± 0.04***,b 48.05
Normal 106.85 ± 4.18 30.95 ± 1.20 4.96 ± 0.19 337.66 ± 6.11 0.54 ± 0.02
CCl4 331.83 ± 9.78
***,a 288.83 ± 11.01***,a 13.40 ± 0.56***,a 598.16 ± 8.97***,a 2.33 ± 0.09***,a
Silymarin 149.66 ± 8.04***,b 54.89 108.63 ± 7.47***,b 62.38 10.40 ± 0.36**,b 22.39 420.50 ± 6.23***,b 29.70 1.03 ± 0.05***,b 55.79
n-Hexane fraction 50 mg 284.66 ± 10.48*,b 14.22 240.00 ± 8.61**,b 16.91 11.93 ± 0.29b 10.97 564.33 ± 14.72b 5.66 2.05 ± 0.13b 12.01
n-Hexane fraction 100 mg 212.50 ± 9.37***,b 35.96 183.83 ± 8.04***,b 36.35 7.40 ± 0.57b 44.77 531.33 ± 22.83*,b 11.17 1.95 ± 0.10*,b 16.31
Normal 101.33 ± 3.08 27.36 ± 1.51 4.73 ± 0.35 326.50 ± 10.55 0.53 ± 0.01
CCl4 319.83 ± 9.11
***,a 248.50 ± 10.00***,a 12.66 ± 0.58***,a 606.83 ± 9.29***,a 2.25 ± 0.10***,a
Silymarin 148.83 ± 6.97***,b 53.46 108.51 ± 5.03***,b 56.33 6.01 ± 0.18***,b 52.53 401.50 ± 9.29***,b 33.84 0.98 ± 0.04***,b 56.44
CHCl3 fraction 50 mg 300.83 ± 9.18
b 5.94 280.50 ± 7.21b – 12.31 ± 0.49b – 596.66 ± 12.58b – 1.98 ± 0.04*,b 12
CHCl3 fraction 100 mg 273.66 ± 8.89
**,b 14.43 237.16 ± 13.47*,b 4.56 8.40 ± 0.39***,b 33.65 510.33 ± 7.13***,b 15.90 1.53 ± 0.07***,b 32
Normal 109.25 ± 4.25 28.40 ± 1.66 5.21 ± 0.21 312.16 ± 10.36 0.54 ± 0.01
CCl4 304.66 ± 7.21
***,a 282.50 ± 8.98***,a 11.83 ± 0.60***,a 586.83 ± 10.36***,a 2.75 ± 0.05***,a
Silymarin 137.83 ± 3.93***,b 54.76 107.16 ± 5.16***,b 62.06 6.53 ± 0.23***,b 44.80 401.33 ± 9.69***,b 31.61 1.50 ± 0.05***,b 45.45
n-Butanol fraction 50 mg 223.33 ± 8.94***,b 26.69 224.66 ± 16.43*,b 20.47 9.96 ± 0.29*,b 15.80 577.50 ± 13.48b – 2.52 ± 0.08b 8.36
n-Butanol fraction
100 mg
193.33 ± 6.43***,b 36.54 145.33 ± 4.55***,b 48.56 8.86 ± 0.45**,b 25.10 532.00 ± 11.98**,b 9.34 2.15 ± 0.09***,b 21.82
* p < 0.05.
** p< 0.01.
*** p< 0.001.
a Compared to normal saline group.
b Compared to Carbon tetrachloride group.
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Table 4 Effect of A. lebbeck fractions on serum lipid metabolism and serum lipoproteins of control and experimental rats.
Treatment (n= 5) Cholesterol (mg/dl) % Change Triglycerides
(mg/dl)
% Change HDL (mg/dl) % Change LDL (mg/dl) % Change VLDL (mg/dl) % Change
Normal 105.16 ± 4.52 60.83 ± 2.70 56.06 ± 2.69 36.92 ± 4.76 12.17 ± 0.54
CCl4 175.66 ± 3.42
***,a 150.33 ± 3.94***,a 25.78 ± 1.78***,a 119.81 ± 4.83***,a 30.06 ± 0.78***,a
Silymarin 152.33 ± 5.60**,b 13.28 127.83 ± 3.41**,b 14.96 38.33 ± 2.40**,b 48.68 87.83 ± 7.20**,b 26.69 25.66 ± 0.68**,b 14.64
n-Hexane fraction 50 mg 160.50 ± 6.30b – 141.00 ± 3.56b – 33.38 ± 1.80*,b 29.48 98.91 ± 6.81*,b 17.44 28.20 ± 0.71b –
n-Hexane fraction 100 mg 155.00 ± 7.15*,b 11.76 131.83 ± 4.07*,b 12.31 35.35 ± 2.75*,b 37.12 93.38 ± 8.98*,b 21.86 26.36 ± 0.81**,b 12.31
Normal 103.96 ± 4.93 68.40 ± 2.04 56.21 ± 2.08 34.07 ± 5.48 13.68 ± 0.40
CCl4 189.66 ± 6.76
***,a 170.66 ± 6.11***,a 26.66 ± 1.02***,a 128.96 ± 6.20***,a 34.03 ± 1.22***,a
Silymarin 148.66 ± 6.72**,b 21.61 123.66 ± 4.42***,b 27.54 42.28 ± 2.05***,b 58.58 83.41 ± 6.81***,b 35.32 24.73 ± 0.88***,b 27.33
CHCl3 fraction 50 mg 165.16 ± 4.47
*,b 12.91 146.16 ± 4.00*,b 14.36 40.51 ± 2.64***,b 51.95 100.00 ± 4.73**,b 22.46 29.23 ± 0.80*,b 14.11
CHCl3 fraction 100 mg 144.33 ± 4.12
***,b 23.90 117.66 ± 4.91***,b 31.05 42.28 ± 1.68***,b 58.58 78.51 ± 4.58***,b 39.12 23.53 ± 0.98***,b 30.86
Normal 100.63 ± 4.32 70.13 ± 3.61 58.61 ± 2.79 28.00 ± 5.32 14.02 ± 0.72
CCl4 196.83 ± 7.42
***,a 172.83 ± 4.32***,a 23.10 ± 1.44***,a 139.16 ± 6.74***,a 34.56 ± 0.86***,a
Silymarin 148.66 ± 6.72**,b 24.47 123.66 ± 4.42***,b 28.45 42.28 ± 2.05***,b 83.03 83.41 ± 6.81***,b 40.06 24.73 ± 0.88***,b 28.44
n-Butanol fraction 50 mg 203.00 ± 10.27b – 159.33 ± 3.73*,b 7.81 34.03 ± 1.69***,b 47.31 137.10 ± 10.82b – 31.86 ± 0.74*,b 7.81
n-Butanol fraction 100 mg 188.50 ± 5.07b – 142.50 ± 3.22***,b 17.55 41.50 ± 1.80***,b 79.65 118.49 ± 4.67*,b 14.85 28.50 ± 0.64***,b 17.53
All values represent mean ± SEM. ANOVA, followed by Dunnett’s multiple comparison test.
* p< 0.05.
** p< 0.01.
*** p< 0.001.
a – as compared to normal saline group.
b – as compared to Carbon tetrachloride group.
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Table 5 Effect of A. lebbeck fractions on NP-SH, MDA and TP in rat liver.
Treatment (n= 5) MDA (nmol/g) NP-SH (nmol/g) Total protein (g/l)
Normal 0.46 ± 0.04 6.01 ± 0.37 98.61 ± 6.74
CCl4 6.37 ± 0.46
***,a 3.37 ± 0.28***,a 25.04 ± 3.41***,a
Silymarin 1.89 ± 0.20***,b 5.84 ± 0.29***,b 59.16 ± 4.50***,b
n-Hexane fraction 50 mg 5.31 ± 0.42b 3.92 ± 0.17b 34.28 ± 2.95b
n-Hexane fraction 100 mg 2.98 ± 0.25***,b 4.61 ± 0.28*,b 51.20 ± 5.56**,b
Normal 0.46 ± 0.03 7.19 ± 0.31 131.20 ± 9.47
CCl4 7.64 ± 0.35
***,a 4.35 ± 0.28***,a 30.20 ± 2.63***,a
Silymarin 2.02 ± 0.21***,b 6.25 ± 0.22***,b 63.53 ± 4.63***,b
CHCl3 fraction 50 mg 5.09 ± 0.42
***,b 3.26 ± 0.16*,b 47.98 ± 3.32**,b
CHCl3 fraction 100 mg 2.87 ± 0.200
***,b 3.35 ± 0.21*,b 72.85 ± 5.80***,b
Normal 0.52 ± 0.04 7.20 ± 0.38 128.44 ± 9.21
CCl4 5.66 ± 0.54
***,a 3.61 ± 0.13***,a 38.54 ± 2.82***,a
Silymarin 1.46 ± 0.19***,b 4.99 ± 0.25***,b 94.98 ± 11.06***,b
n-Butanol fraction 50 mg 4.46 ± 0.29***,b 4.30 ± 0.32b 59.24 ± 4.83**,b
n-Butanol fraction 100 mg 1.82 ± 0.20***,b 4.50 ± 0.30*,b 82.19 ± 7.19***,b
All values represent mean ± SEM. ANOVA, followed by Dunnett’s multiple comparison test.
* p< 0.05.
** p< 0.01.
*** p< 0.001.
a – as compared to Normal saline group.
b – as compared to Carbon tetrachloride group.
Secondary metabolites from fraction of Albizia lebbeck flowers 9(dd, J= 11.1, 5.8 Hz), 4.11 (dd, J= 11.5, 1.9 Hz) and dH 3.90
(dd, J= 12.6, 2.1 Hz), 3.66 (brd, J= 12.4 Hz) assigned for
Glc-6 and Ara-5. The remaining protons and carbons data
for b-D-glucose and a-L-arabinose were matched with those
reported (Nakamura et al., 2007) and with the glycosides iso-
lated from the currently studied plant (compounds 5–8)
(Nakamura et al., 2008; Yang et al., 2013; Yoshikawa et al.,
1996). The linkage between the two sugar moieties was found
to be (1? 6) by clear downfield shift of C-6 of b-D-glucose
(dC 69.5 ppm) and significant three bond correlations,
observed in HMBC spectrum, from the protons at dH 3.76,
4.11 ppm (H-60a and H-60b) and the anomeric carbon of arabi-
nose resonating at dC 105.1 ppm. On the other hand, the link-
age, between the farnesyl and the sugar moiety, was proved to
be at C-1 of the aglycone by a significant downfield shift of C-1
of the farnesol (dC 66.7) as well as the three bond correlation,
observed in HMBC experiment, between H-1 (dH 4.21, 4.36)
and the b-D-glucose anomeric carbon at dC 103.0 ppm and
the above aforementioned data prove compound 6 to be
1-O-[6-O-a-L-arabinopyranosyl b-D-glucopyranoside]-(2E,6E-)-
farnesol. It is worth to note that crenulatoside derivatives (A-
G) have been isolated before from Guioa crenulata (Magid
et al., 2005).
Based on collective data, compound 9 (2,3-dihydroxy-2,3-
dihydrosqualene), is identified here from natural source for
the first time. However, it was previously synthesized (Brown
and Martens, 1977) and also used as precursor in the synthesis
of squalene oxides (D’Accolti et al., 2005).
This study proved that A. lebbeck is a rich source of ter-
penoid compounds, where we isolate mono, sesqui and triter-
penes derivatives. Moreover the sugar part of the isolated
biosides (compounds 4–8) consists of a-L-arabinopyranosyl
(1? 6)b-D-glucopyranoside and this finding is considered as
a chemotaxonomic marker for genus Albizia.Please cite this article in press as: Al-Massarani, S.M. et al., New acyclic secondary m
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